ME Therapeutics Holdings Inc.
Preclinical stage Vancouver based biotechnology company involved in the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer. Focussed on drugs targeting myeloid cells.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}